KEUCH v. TEVA PHARMACEUTICALS USA, INC. et al, No. 2:2019cv05488 - Document 30 (E.D. Pa. 2020)
Court Description: MEMORANDUM OPINION ORDER THAT THE MOTION TO DISMISS (DOC. NO. 25 ) IS GRANTED IN PART AND DENIED IN PART. DEFENDANTS SCHULTZ AND YANIV ARE DISMISSED WITH PREJUDICE. KEUCH MAY SUBMIT NO MORE THAN TEN INTERROGATORIES AND TEN DOCUMENT REQUESTS ON TEVA WORLDWIDE AND/OR TEVA US RELATED TO TEVA WORLDWIDE'S INVOLVEMENT IN KEUCH'S TERMINATION. KEUCH MAY FILE AN AMENDED COMPLAINT BY 1/19/21. SIGNED BY MAGISTRATE JUDGE TIMOTHY R. RICE ON 11/19/20. 11/23/20 ENTERED AND COPIES E-MAILED.(amas, )
Download PDF
<![CDATA[
KEUCH v. TEVA PHARMACEUTICALS USA, INC. et al Doc. 30 Case 2:19-cv-05488-TR Document 30 Filed 11/23/20 Page 1 of 1 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA RANDOLPH KEUCH, Plaintiff, v. TEVA PHARMACEUTICALS USA, INC., et al., Defendants. : : : : : : : : CIVIL ACTION No. 19-5488 ORDER AND NOW, on November 19, 2020, upon consideration of Defendants Teva Worldwide, Käre Schultz, and Ron Yaniv’s Motion to Dismiss (doc. 25), Plaintiff Randolph Keuch’s Memorandum in Opposition (doc. 27), and Teva Worldwide, Schultz, and Yaniv’s Reply (doc. 28), the motion is GRANTED, in part, and DENIED, in part. 1. Defendants Schultz and Yaniv are dismissed with prejudice. 2. Keuch may submit no more than ten interrogatories and ten document requests on Teva Worldwide and/or Teva US related to Teva Worldwide’s involvement in Keuch’s termination. 3. Based on that discovery, Keuch may file an amended complaint by January 19, 2021. BY THE COURT: /s/ Timothy R. Rice TIMOTHY R. RICE U.S. MAGISTRATE JUDGE Dockets.Justia.com
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
